Provided by Tiger Trade Technology Pte. Ltd.

Alector Inc.

1.48
-0.0100-0.67%
Post-market: 1.480.00000.00%19:38 EDT
Volume:325.30K
Turnover:483.11K
Market Cap:164.32M
PE:-1.25
High:1.51
Open:1.50
Low:1.46
Close:1.49
52wk High:3.40
52wk Low:1.09
Shares:111.03M
Float Shares:96.53M
Volume Ratio:0.68
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1853
EPS(LYR):-1.3900
ROE:-238.85%
ROA:-25.71%
PB:15.83
PE(LYR):-1.06

Loading ...

Alector (ALEC) Gets a Hold from Mizuho Securities

TIPRANKS
·
Jul 10

UK Stocks-factors to Watch on July 9

Reuters
·
Jul 09

Alector - GSK Terminates Collaboration and License Agreement with Alector Effective January 2, 2027 - SEC Filing

THOMSON REUTERS
·
Jul 09

Alector - Repays and Terminates Loan Agreement, Repays $10.43 Mln in Principal - SEC Filing

THOMSON REUTERS
·
Jul 09

Alector Repays USD 10.43 Million Hercules Loan, Terminates Credit Agreement

Reuters
·
Jul 09

Alector shareholders ratify Ernst & Young as auditor for fiscal 2026

Reuters
·
Jun 18

Alector Principal Accounting Officer Grace Wong-Sarad disposes of USD 17,835 in common shares

Reuters
·
Jun 04

Analysts Are Bullish on These Healthcare Stocks: BeOne Medicines (ONC), Alector (ALEC)

TIPRANKS
·
May 09

Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), McKesson (MCK) and Alector (ALEC)

TIPRANKS
·
May 08

Alector enters equity distribution deal with TD Cowen for up to $125 million shares

Reuters
·
May 08

Alector Q1 revenue drops but costs cuts help loss narrow

Reuters
·
May 08

Alector Q1 EPS $(0.21) Beats $(0.35) Estimate, Sales $1.046M Miss $6.207M Estimate

Benzinga
·
May 08

BRIEF-Alector Q1 Basic EPS USD -0.21

Reuters
·
May 08

Alector Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
May 04

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Alector (ALEC)

TIPRANKS
·
Apr 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC) and Alector (ALEC)

TIPRANKS
·
Apr 30

Alector halts Phase 2 nivisnebart early Alzheimer’s trial after futility analysis

Reuters
·
Apr 30

BRIEF-Alector To Discontinue Phase 2 Trial Of Nivisnebart

Reuters
·
Apr 30

Alector Inc - Targets Ind Application for Al050 Enzyme Replacement Therapy in 2027

THOMSON REUTERS
·
Apr 30